Pancreatic Cancer Research

ResearcherThe University of OsakaNo recent work listed

Daisuke Takiuchi

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5002651923. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper

Papers 4

  1. [A Case of Pancreatic Pseudocyst Recurrence after Surgery for Remnant Pancreatic Cancer]. First author PMID 35046330↗
  2. [A Case Report of Long Survival in Pancreatic Cancer with Superior Mesenteric Arterial Invasion Following Multimodal Therapy]. Co-author PMID 32156925↗
  3. [Multidisciplinary therapy for recurrent pancreatic cancer]. Co-author PMID 25731460↗
  4. Involvement of microRNA-181b in the gemcitabine resistance of pancreatic cancer cells. Co-author DOI 10.1016/j.pan.2013.06.007↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Osakuni Morimoto · 3 shared papers, 2014–2021 · strength 0.23
  2. Yusuke Akamaru · 2 shared papers, 2019–2021 · strength 0.19
  3. Hirotsugu Ohashi · 2 shared papers, 2019–2021 · strength 0.19
  4. Kunitaka Shibata · 2 shared papers, 2014–2019 · strength 0.12
  5. Takahiro Shimaoka · 1 shared paper, 2021 · strength 0.11
  6. Kunitaka Shibata · 1 shared paper, 2021 · strength 0.11
  7. Masahiro Tanemura · 1 shared paper, 2013 · strength 0.03
  8. Yuichiro Doki · 1 shared paper, 2013 · strength 0.03
  9. Yoshifumi Iwagami · 1 shared paper, 2013 · strength 0.03
  10. Hidetoshi Eguchi · 1 shared paper, 2013 · strength 0.03
  11. Yoshito Tomimaru · 1 shared paper, 2013 · strength 0.03
  12. Shigeru Marubashi · 1 shared paper, 2013 · strength 0.03
  13. Hiroaki Nagano · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.